Toxic epidermal necrolysis is a life-threatening skin disorder characterized by blistering and peeling of the skin. This condition can be caused by a reaction to certain drugs, including antibiotics or anticonvulsives, but about one-third of all cases of toxic epidermal necrolysis do not have an identifiable cause.
Toxic epidermal necrolysis causes the skin to peel in sheets, leaving large, raw areas. The loss of skin allows fluids and salts to ooze from the damaged areas, and the exposed areas can become infected.
The following are the most common symptoms of toxic epidermal necrolysis. However, each child may experience symptoms differently.
The symptoms of toxic epidermal necrolysis may resemble other skin conditions. Always consult a physician for the correct diagnosis.
This disease progresses fast, usually within 3 days. Treatment usually includes hospitalization, often in the burn unit. If a medication is causing the skin reaction, it is immediately discontinued.
Specific treatment for toxic epidermal necrolysis will be determined based on:
Treatment may include one or more of the following:
The Division of Dermatology at Children's National Health System continues to expand services as more families seek our expertise in the diagnosis and treatment of disorders of the skin, hair, and nails.
Invest in future cures for some of life's most devastating diseases
Keep in touch with Children's National by signing up for our newsletters.
Located within Children's National Health System, the Regional Outpatient Centers' administrative offices support outreach to the community and facilitates hospital department participation in the program. The Regional Outpatient Centers offer Children's specialists in a neighborhood setting around the region.
Seborrheic dermatitis, also known as cradle cap, is characterized by fine white scales on the head and scalp.
Skin color is determined by pigment (melanin) made by specialized cells in the skin called melanocytes. The amount and type of melanin determines a person's skin color.